扫描下面的二维码:

二维码

"热点聚焦"标签列表

[EASL重磅]3D方案治疗HIV/HCV难治人群数据荟萃及最新进展2016-05-05

[EASL重磅]DAA治疗HCV合并肝硬化患者可获高SVR和肝纤维化逆转2016-05-05

[EASL热点透视]唐红教授点评:DAA时代,肝移植后HCV感染复发患者是否需加用联合利巴韦林治疗?2016-04-17

[PHC视点]慢性HCV感染的优化治疗:疗程可以安全缩短吗?2016-03-11

[PHC视点]病例分享:慢性乙型肝炎的一线治疗2016-03-10

[PHC视点]哪些HCV感染患者应该接受治疗?2016-03-09

[病例分享]先天性非溶血性高胆红素血症1例2016-03-07

肝癌诊疗新工具ARCHTECT PIVKA-II2016-03-03

New Endpoints in HBV Drug Development2016-03-02

Portal Vein Thrombosis in Cirrhotic and Non-cirrhotic Liver2016-03-02

New Drugs to Overwhelm the Barriers to Eliminate HCV2016-03-02

Welcome Message——Jinlin Hou2016-03-02

AARC-ACLF, the Better Prognostic Score—AARC-ACLF Score predicts 30-day survival better than CLIF-SOFA2016-03-02

LDV/SOF Efficacious in HCV Patients with Decompensated Cirrhosis2016-03-02

VEL/SOF Effective in HCV Patients with Decompensated Cirrhosis2016-03-02

Radiofrequency Ablation (RFA) Know-How in 2 Days — Juntendo University radiofrequency ablation (RFA) training program2016-03-02

REP2139-Ca, a Promising NAP to Treat HBV2016-03-02

At 38 years, just Young and Robust—25th APASL Opening Ceremony2016-03-02

For HBV/HCV Co-infection Patients in DAA Era, Treat the Viruses both!2016-03-02

Hepatitis B Treatment: Yesterday, Today and Tomorrow2016-03-02



设为首页 | 加入收藏 | 网站地图 | 订阅杂志 | 关于我们 | 版权声明 | 联系方式|招贤纳士
国际肝病  版权所有  京ICP备15060708号   (京)-非经营性-2016-0001京公网安备 11010502033341号 2004-2020  www.ihepa.com  ALL Rights  Reserved

增值电信业务经营许可证:京B2-20212326

网站统计